In the Original Investigation titled “Association of Chemotherapy, Enzalutamide, Abiraterone, and Radium 223 With Cognitive Function in Older Men With Metastatic Castration-Resistant Prostate Cancer,”1 published July 2, 2021, the number of men studied was given incorrectly in the Key Points section; it now reads 155. The article was corrected on July 29, 2021.
References
- 1.Alibhai SMH, Breunis H, Feng G, et al. Association of chemotherapy, enzalutamide, abiraterone, and radium 223 with cognitive function in older men with metastatic castration-resistant prostate cancer. JAMA Netw Open. 2021;4(7):e2114694. doi: 10.1001/jamanetworkopen.2021.14694 [DOI] [PMC free article] [PubMed] [Google Scholar]
